For example, when selecting a prostate cancel model for PSMA, LNCaP and CWR22Rv1 prostate cancer cells endogenously exhibit significant PSMA expression, while PC3 and DU145 prostate cancer cells do not express PSMA 135. Here, FOLH1 is linked to prostate carcinoma.